Influenza Virus and SARS-CoV-2 Vaccines.
Saved in:
| Title: | Influenza Virus and SARS-CoV-2 Vaccines. |
|---|---|
| Authors: | Sandor AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and., Sturdivant MS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Biological and Biomedical Sciences Program, University of North Carolina at Chapel Hill, Chapel Hill, NC., Ting JPY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; jenny_ting@med.unc.edu.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC. |
| Source: | Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Jun 01; Vol. 206 (11), pp. 2509-2520. Date of Electronic Publication: 2021 May 21. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
